Clinical Trials Directory

Trials / Completed

CompletedNCT00550602

Tracheobronchomalacia: Treatment Outcomes

Status
Completed
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Beth Israel Deaconess Medical Center · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate respiratory symptoms and their impact in the quality of life and after treatment of the respiratory condition (tracheobronchomalacia - TBM).

Detailed description

TBM is an abnormal collapse of the tracheal and bronchial walls. It is characterized by flaccidity of the supporting tracheal and bronchial structures and a significant reduction of airway diameter on expiration seen in the trachea and/or in the mainstem bronchi. Currently there is no available data on the efficacy of central airway stabilization for treating TBM. Our study would provide this important information and would establish the effect of central airway stabilization on symptoms, functional status, quality of life, lung function and exercise capacity in patients with symptomatic and severe TBM.

Conditions

Timeline

Start date
2002-01-01
Primary completion
2010-03-01
Completion
2010-03-01
First posted
2007-10-30
Last updated
2017-02-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00550602. Inclusion in this directory is not an endorsement.